Amgen
Trade Amgen 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About AMGN
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K.
AMGN Key Statistics
Stock Snapshot
The current Amgen(AMGN) stock price is $379.38, with a market capitalization of 205.31B. The stock trades at a price-to-earnings (P/E) ratio of 23.38 and offers a dividend yield of 2.64%.
On 2026-09-17, Amgen(AMGN) stock traded between a low of $376.08 and a high of $382.49. Shares are currently priced at $379.38, which is +0.9% above the low and -0.8% below the high.
The Amgen(AMGN)'s current trading volume is 3.19M, compared to an average daily volume of 2.9M.
In the last year, Amgen(AMGN) shares hit a 52-week high of $447.03 and a 52-week low of $269.77.
In the last year, Amgen(AMGN) shares hit a 52-week high of $447.03 and a 52-week low of $269.77.
AMGN News
Amgen Inc (AMGN) announced an update on their ongoing clinical study. Amgen Inc. (AMGN) is running a Phase 3 study testing romiplostim plus predniso(lo)ne agai...
Citi analyst Geoff Meacham maintained a Hold rating on Amgen yesterday and set a price target of $405.00. Geoff Meacham has given his Hold rating due to a comb...
Key Points Amgen has proven that it can manage market downturns fairly well. The company is also an excellent dividend stock. The drugmaker is a top pick for...
Analyst ratings
56%
of 36 ratingsMore AMGN News
September is historically known as the worst-performing month for U.S. equities. According to the 2026 Stock Trader’s Almanac, the S&P 500 index has recorded an...
Amgen (NASDAQ:AMGN) outlined its growth priorities, late-stage pipeline progress and capital-allocation framework during a Morgan Stanley conference, as newly a...
Amgen (NasdaqGS:AMGN) received an FDA label update for IMDELLTRA that shortens recommended monitoring for the first two doses. The revised guidance is expected...
Key Points VanEck Pharmaceutical ETF offers a higher dividend yield and a lower beta profile than VanEck Biotech ETF. VanEck Biotech ETF has delivered a highe...
Veeva Systems (VEEV) announced that Amgen (AMGN) plans to deploy Veeva Vault CRM globally, building on a collaboration spanning more than a decade. “Moving to V...
Amgen Inc (AMGN) announced an update on their ongoing clinical study. The phase 3 study A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluat...
(RTTNews) - Amgen (AMGN) announced the FDA approved an update to the IMDELLTRA Prescribing Information that substantially reduces the recommended monitoring tim...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.